Mad in America

MAY 3, 2025

There are many patients who have been diagnosed with so-called serious mental illness (such as so-called schizophrenia and bipolar disorder) who ultimately reject psychiatric treatment including psychiatric drugs, and become highly functioning. medical schools.

Trauma and the brain 130

Trauma and the brain Aging and mental health Genetics and mental health Bipolar disorder 130

Mad in America

MARCH 15, 2025

This turn to ketamine is occurring despite the fact that the Food and Drug Administration has repeatedly warned that the FDA has not approved ketamine for the treatment of any psychiatric disorder (though controversially approving esketamine nasal spray). million in consulting fees from drug makers from 2000 to 2007.

Neurotransmitters and mental health 134

Neurotransmitters and mental health Trauma and the brain Manufacturing Pharmaceuticals 134

Mad in America

OCTOBER 21, 2023

One of many psychiatrists exposed by 2008 Congressional hearings on psychiatry’s financial relationship with drug companies was Harvard psychiatrist Joseph Biederman—credited with creating pediatric bipolar disorder—who received $1.6 million in consulting fees from drug makers from 2000 to 2007.

Technology 144

Technology Genetics and mental health Pharmaceuticals Sleep and mental health 144

Mad in America

MAY 6, 2025

8,9,11-14 In 2019, a Norwegian study found that 52 of 100 consecutively admitted patients to a psychiatric hospital would have wanted a drug-free alternative if it had existed. I was once invited to follow the chief psychiatrist during one day at a closed ward at my hospital, Rigshospitalet. HHSA 290 2007 10060 I.) 3 Whitaker R.

Neurotransmitters and mental health 142

Neurotransmitters and mental health Genetics and mental health Aging and mental health Hospitality 142